<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35869263</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic lateral sclerosis and cerebellum.</ArticleTitle><Pagination><StartPage>12586</StartPage><MedlinePgn>12586</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12586</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-16772-5</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating, heterogeneous neurodegenerative neuromuscular disease that leads to a fatal outcome within 2-5&#xa0;years, and yet, a precise nature of the association between its major phenotypes and the cerebellar role in ALS pathology remains unknown. Recently, repeat expansions in several genes in which variants appreciably contribute to cerebellar pathology, including C9orf72, NIPA1, ATXN2 and ATXN1, have been found to confer a significant risk for ALS. To better define this relationship, we performed MAGMA gene-based analysis and tissue enrichment analysis using genome-wide association study summary statistics based on a study of 27,205 people with ALS and 110,881 controls. Our preliminary results imply a striking cerebellar tissue specificity and further support increasing calls for re-evaluation of the cerebellar role in the ALS pathology.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kabiljo</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK. renata.kabiljo@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenzweig</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neuroimaging, Sleep and Brain Plasticity Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>AL-CHALABI/APR15/844-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>103952/Z/14/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR202421</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-DOBSON/APR14/829-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35869263</ArticleId><ArticleId IdType="pmc">PMC9307771</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-16772-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-16772-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A, Van Den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazelaar GHP, et al. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. Brain Commun. 2020;2:fcaa064. doi: 10.1093/braincomms/fcaa064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa064</ArticleId><ArticleId IdType="pmc">PMC7425293</ArticleId><ArticleId IdType="pubmed">32954321</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi M, et al. Adaptive functional reorganization in amyotrophic lateral sclerosis: Coexisting degenerative and compensatory changes. Eur. J. Neurol. 2020;27:121&#x2013;128. doi: 10.1111/ene.14042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14042</ArticleId><ArticleId IdType="pubmed">31310452</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF. The cerebellum in ALS: Friend or foe? J. Neurol. Neurosurg. Psychiatry. 2021;92:1137. doi: 10.1136/jnnp-2021-327216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327216</ArticleId><ArticleId IdType="pubmed">34341140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, et al. Genotype-associated cerebellar profiles in ALS: Focal cerebellar pathology and cerebro-cerebellar connectivity alterations. J. Neurol. Neurosurg. Psychiatry. 2021;92:1197&#x2013;1205. doi: 10.1136/jnnp-2021-326854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326854</ArticleId><ArticleId IdType="pmc">PMC8522463</ArticleId><ArticleId IdType="pubmed">34168085</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi M, et al. Neural correlates of motor imagery of gait in amyotrophic lateral sclerosis. J. Magn. Reson. Imaging. 2021;53:223&#x2013;233. doi: 10.1002/jmri.27335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27335</ArticleId><ArticleId IdType="pubmed">32896088</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton FA, Strick PL. Cerebellar projections to the prefrontal cortex of the primate. J. Neurosci. 2001;21:700&#x2013;712. doi: 10.1523/JNEUROSCI.21-02-00700.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-02-00700.2001</ArticleId><ArticleId IdType="pmc">PMC6763818</ArticleId><ArticleId IdType="pubmed">11160449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, et al. Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology. 2013;81:2107&#x2013;2115. doi: 10.1212/01.wnl.0000437313.80913.2c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000437313.80913.2c</ArticleId><ArticleId IdType="pubmed">24212388</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambra, A. F., Jung, S. J., Ganesan, S., Antzoulatos, E. G. &amp; Fioravante, D. Cerebellar Activation Bidirectionally Regulates Nucleus Accumbens Medial Shell and Core. 10.1101/2020.09.28.283952 (2021).</Citation></Reference><Reference><Citation>Ballard IC, et al. Dorsolateral prefrontal cortex drives mesolimbic dopaminergic regions to initiate motivated behavior. J. Neurosci. 2011;31:10340&#x2013;10346. doi: 10.1523/JNEUROSCI.0895-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0895-11.2011</ArticleId><ArticleId IdType="pmc">PMC3182466</ArticleId><ArticleId IdType="pubmed">21753011</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: Generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 2015;11:e1004219. doi: 10.1371/journal.pcbi.1004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 2021;53:1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 2017;8:1826. doi: 10.1038/s41467-017-01261-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01261-5</ArticleId><ArticleId IdType="pmc">PMC5705698</ArticleId><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium, G. T Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 2015;348:648&#x2013;660. doi: 10.1126/science.1262110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1262110</ArticleId><ArticleId IdType="pmc">PMC4547484</ArticleId><ArticleId IdType="pubmed">25954001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>